N-[4-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-a]pyridin-6-yl}oxy)3-fluorophenyl]-6-methyl-2-oxo-1-phenyl-1,2-dihydropyridine-3-carboxamide hydrochloride

ID: ALA3765306

Chembl Id: CHEMBL3765306

PubChem CID: 127041352

Max Phase: Preclinical

Molecular Formula: C30H26ClFN5O4+

Molecular Weight: 538.56

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1=[N+](c2ccccc2)C(=O)C(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c(F)c2)C=C1.Cl

Standard InChI:  InChI=1S/C30H24FN5O4.ClH/c1-18-7-12-23(30(39)36(18)21-5-3-2-4-6-21)29(38)32-20-10-13-25(24(31)15-20)40-22-11-14-27-33-26(17-35(27)16-22)34-28(37)19-8-9-19;/h2-7,10-17,19,23H,8-9H2,1H3,(H-,32,34,37,38);1H/p+1

Standard InChI Key:  BIEQEAYPFKISHJ-UHFFFAOYSA-O

Associated Targets(Human)

MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 (6262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT4 Tclin Vascular endothelial growth factor receptor 3 (3216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 538.56Molecular Weight (Monoisotopic): 538.1885AlogP: 5.07#Rotatable Bonds: 7
Polar Surface Area: 104.81Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.90CX Basic pKa: 3.26CX LogP: 1.27CX LogD: 1.32
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.25Np Likeness Score: -1.31

References

1. Zhang J, Jiang X, Jiang Y, Guo M, Zhang S, Li J, He J, Liu J, Wang J, Ouyang L..  (2016)  Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.,  108  [PMID:26717201] [10.1016/j.ejmech.2015.12.016]

Source